Skip to main content

Living with Alzheimer’s-Related Agitation?

Explore Agitation in Alzheimer’s Clinical Trials in Michigan

Alzheimer’s disease is a progressive neurological condition that affects memory, thinking, and behavior. In addition to cognitive decline, many individuals experience agitation, which may include restlessness, irritability, emotional distress, or aggressive behaviors. These symptoms can be difficult for patients and place significant emotional and physical strain on caregivers.

Agitation is a common but often under-recognized symptom of Alzheimer’s disease. When left unmanaged, it can interfere with daily routines, disrupt sleep, and reduce overall quality of life.
It may also increase emotional distress for both patients and caregivers, making everyday interactions more challenging.

Revival Research Institute is conducting Alzheimer’s clinical trials to evaluate an investigational treatment that may potentially reduce agitation in Alzheimer’s patients. These Alzheimer’s research studies are designed to explore safe and effective approaches to managing agitation while advancing future treatment options.

Are You Eligible to Participate?

To participate in our Alzheimer’s disease clinical trials in Michigan, individuals must meet the following criteria:

  • Male & female, 50 years of age or older
  • Has a diagnosis of dementia
  • Has onset of agitation symptoms at least 2 weeks prior to Visit 1

*Additional criteria may apply.

Participation in Alzheimer’s disease clinical trials in Michigan or other locations provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Who is this information for?**

Please provide YOUR contact information only.

Name*
Best Time to Call*
User Agreement*

This is our Privacy Policy.

Agitation in Alzheimer's Clinical Trial Flyer

About the Agitation in Alzheimer’s Clinical Trial

Agitation is one of the most challenging behavioral symptoms associated with Alzheimer’s disease. It can increase caregiver stress, lead to early placement in long-term care, and negatively affect patient well-being. These symptoms can vary in intensity and frequency, making daily care more unpredictable.

Revival Research Institute is conducting Alzheimer’s clinical trials to evaluate the safety and effectiveness of an investigational treatment for Alzheimer disease focused on managing agitation.

Clinical Trials for Alzheimer’s – related agitation will be conducted in several locations across the United States, including Michigan. To ensure study eligibility, all participants must comply with all study procedures. Participants who meet the eligibility criteria after undergoing the screening phase and are chosen to participate will be given the placebo or study treatment.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate, and participants may receive compensation for time and travel.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. A brief discussion about your health and medical history may be required.

Get Started: What to Expect?

If you or a loved one is experiencing agitation related to Alzheimer’s disease, you may qualify for a paid clinical trial focused on potential treatment options for this condition. After completing the interest form above, a research team member will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you’ll be invited to a screening visit at our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the clinical trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask any questions before enrolling. Your participation will help advance new approaches to Alzheimer’s research studies.

Age

50 years or older

Condition

Alzheimer’s related Agitation

Location

Dearborn, Michigan

Understanding Alzheimer’s-Related Agitation

Agitation in Alzheimer's Clinical Trial

Agitation due to Alzheimer’s Disease May Include:

  • Restlessness or pacing
  • Verbal or physical agitation
  • Anxiety or irritability
  • Resistance to care
  • Sleep disturbances

Common Signs & Symptoms include:

  • Sudden behavioral changes
  • Emotional distress or frustration
  • Increased confusion
  • Difficulty calming down
  • Heightened caregiver burden

Current treatment options may include behavioral strategies and medications; however, results vary. Alzheimer’s with agitation research studies in Michigan provide access to investigational treatments being evaluated for safety and effectiveness.

Frequently Asked Questions (FAQs)

What is agitation in Alzheimer’s disease?

Agitation in Alzheimer’s disease refers to behavioral symptoms such as restlessness, irritability, emotional distress, or aggressive behavior that may occur as the disease progresses.

Can agitation be managed in people with Alzheimer’s disease?

Agitation in Alzheimer’s disease can sometimes be managed through a combination of supportive care approaches, structured routines, and medical guidance.

What role does a caregiver play in an Alzheimer’s agitation clinical study?

Caregivers play an important role by helping support daily routines, attending study visits when needed, and sharing observations about symptoms and behaviors. Their involvement helps ensure participant safety and provides valuable insight into day-to-day experiences.

Do I need insurance to participate?

No, insurance is not required to take part in this clinical trial. All study-related treatments and procedures are provided at no cost.

Why should I participate in an Alzheimer’s clinical trial?

By enrolling in clinical trials for Alzheimer’s, you may access investigational treatment, receive expert medical care, and contribute to advancing research that may improve future care for individuals affected by Alzheimer’s disease.

Close Menu







    Your information is confidential and used only for study enrollment purposes.








      Your information is confidential and used only for study enrollment purposes.








        Your information is confidential and used only for study enrollment purposes